Abstract
Epstein–Barr virus (EBV), a human herpesvirus associated with lymphoid and epithelial cell tumors, encodes several proteins that exploit the ubiquitin–proteasome system to regulate latency and allow the persistence of infected cells in immunocompetent hosts. Further modifications of ubiquitin-dependent proteolysis by activated cellular oncogenes contribute to malignant transformation. A detailed understanding of these processes may lead to the development of new therapeutic strategies for EBV-associated cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersson ML, Stam NJ, Klein G, Ploegh HL and Masucci MG . (1991). Int. J. Cancer, 47, 544–550.
Aumuller G, Renneberg H, Leonhardt M, Lilja H and Abrahamsson PA . (1999). Prostate, 38, 261–267.
Aviel S, Winberg G, Masucci MG and Ciechanover A . (2000). J. Biol. Chem., 275, 23491–23499.
Avila-Carino J, Torsteinsdottir S, Ehlin-Henriksson B, Lenoir G, Klein G, Klein E and Masucci MG . (1987). Int. J. Cancer, 40, 691–697.
Babcock GJ, Decker LL, Freeman RB and Thorley-Lawson DA . (1999). J. Exp. Med., 190, 567–576.
Babcock GJ, Decker LL, Volk M and Thorley-Lawson DA . (1998). Immunity, 9, 395–404.
Babcock GJ, Hochberg D and Thorley-Lawson AD . (2000). Immunity, 13, 497–506.
Babcock GJ and Thorley-Lawson DA . (2000). Proc. Natl. Acad. Sci. USA, 97, 12250–12255.
Bahram F, von der Lehr N, Cetinkaya C and Larsson LG . (2000). Blood, 95, 2104–2110.
Balakirev MY, Tcherniuk SO, Jaquinod M and Chroboczek J . (2003). EMBO Rep., 4, 517–522.
Balow RM and Eriksson I . (1987). Biochem. J., 241, 75–80.
Balow RM, Ragnarsson U and Zetterqvist O . (1983). J. Biol. Chem., 258, 11622–11628.
Balow RM, Tomkinson B, Ragnarsson U and Zetterqvist O . (1986). J. Biol. Chem., 261, 2409–2417.
Blake N, Lee S, Redchenko I, Thomas W, Steven N, Leese A, Steigerwald-Mullen P, Kurilla MG, Frappier L and Rickinson A . (1997). Immunity, 7, 791–802.
Blake NW, Moghaddam A, Rao P, Kaur A, Glickman R, Cho YG, Marchini A, Haigh T, Johnson RP, Rickinson AB and Wang F . (1999). J. Virol., 73, 7381–7389.
Bloom J, Amador V, Bartolini F, DeMartino G and Magano M . (2003). Cell, 115, 71–82.
Borodovsky A, Ovaa H, Kolli N, Gan-Erdene T, Wilkinson KD, Ploegh HL and Kessler BM . (2002). Chem. Biol., 9, 1149–1159.
Boutell C, Dasis S and Everett RD . (2002). J. Virol., 76, 841–850.
Boutell C and Everett R . (2003). J. Biol. Chem., 278, 36596–36602.
Breitschopf K, Bengal E, Ziv T, Admon A and Ciechanover A . (1998). EMBO J., 17, 5964–5973.
Brichory F, Beer D, Le Naour F, Giordano T and Hanash S . (2001). Cancer Res., 61, 7908–7912.
Brown KD, Hostager BS and Bishop GA . (2001). J. Exp. Med., 193, 943–954.
Chen F, Zou J-Z, di Renzo L, Winberg G, Hu L-F, Klein E, Klein G and Ernberg I . (1995). J. Virol., 69, 3752–3758.
Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV and Deshaies RJ . (2002). Science, 298, 608–611.
Coscoy L and Ganem D . (2001). J. Clin. Invest., 107, 1599–1606.
Curran JA, Laverty FS, Campbell D, Macdiarmid J and Wilson JB . (2001). Cancer Res., 61, 6730–6738.
D'Andrea V, Malinovsky L, Berni A, Biancari F, Biassoni L, Di Matteo FM, Corbellini L, Falvo L, Santoni F, Spyrou M and De Antoni E . (1997). G. Chir., 18, 521–524.
Dantuma N, Heesseen S, Lindsten K, Jellne M and Masucci MG . (2000a). Proc. Natl. Acad. Sci. USA, 97, 8381–8385.
Dantuma N, Lindsten K, Glas R, Jellne M and Masucci MG . (2000b). Nat. Biotechnol., 18, 538–543.
Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C and Chen ZJ . (2000). Cell, 103, 351–361.
Dolcetti R and Masucci MG . (2003). J. Cell. Physiol., 196, 207–218.
Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E and Middeldorp JM . (2000). J. Immunol., 165, 663–670.
Engels N, Merchant M, Pappu R, Chan AC, Longnecker R and Wienands J . (2001). J. Exp. Med., 194, 255–264.
Everett RD, Meredith M, Orr A, Cross A, Kathorai M and Parkinson J . (1997). EMBO J., 16, 1519–1530.
Falk K, Gratama JW, Rowe M, Zou JZ, Khanim F, Young LS, Oosterveer MAP and Ernberg I . (1995). J. Gen. Virol., 76, 779–790.
Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY and Botas J . (2000). Nature, 408, 101–106.
Frisan T, Levitsky V, Polack A and Masucci MG . (1998). J. Immunol., 160, 3281–3289.
Frisan T, Zhang QJ, Levitskaya J, Coram M, Kurilla MG and Masucci MG . (1996). Int. J. Cancer, 68, 251–258.
Fruh K, Bartee E, Gouveia K and Mansouri M . (2002). Virus Res., 88, 55–69.
Gavioli R, Frisan T, Vertuani S, Bornkamm GW and Masucci MG . (2001). Nat. Cell. Biol., 3, 283–288.
Geier E, Pfeifer G, Wilm M, Lucchiari-Hartz M, Baumeister W, Eichmann K and Niedermann G . (1999). Science, 283, 978–981.
Glas R, Bogyo M, McMaster JS, Gaczynska M and Ploegh HL . (1998). Nature, 392, 618–622.
Glickman MH and Ciechanover A . (2002). Physiol. Rev., 82, 373–428.
Gregory MA and Hann SR . (2000). Mol. Cell. Biol., 20, 2423–2435.
Heessen S, Dantuma N, Tessarz P, Jellne M and Masucci MG : FEBS Lett., 555, 397–404.
Heessen S, Leonchiks A, Isseva N, Sharipo A, Selivanova G, Masucci MG and Dantuma N . (2002). Proc. Natl. Acad. Sci. USA, 99, 1532–1537.
Hemelaar J, Bex F, Booth B, Cerundolo V, McMichael A and Daenke S . (2001). J. Virol., 75, 11106–11115.
Herbst H . (1996). Semin. Cancer Biol., 7, 183–189.
Hilbi H, Puro RJ and Zychlinsky A . (2000). Infect. Immun., 68, 5502–5508.
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C and Frappier L . (2003a). J. Biol. Chem., 278, 47753–47761.
Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, Greenblatt J and Frappier L . (2003b). J. Biol. Chem., 278, 29987–29994.
Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G and Winberg G . (1993). Oncogene, 8, 1575–1583.
Iezzoni JC, Gaffey MJ and Weiss LM . (1995). Am. J. Clin. Pathol., 103, 308–315.
Ikeda A, Caldwell RG, Longnecker R and Ikeda M . (2003). J. Virol., 77, 5529–5534.
Ikeda M, Ikeda A, Longan LC and Longnecker R . (2000). Virology, 268, 178–191.
Ikeda M, Ikeda A and Longnecker R . (2002). Virology, 300, 153–159.
Kelly G, Bell A and Rickinson A . (2002). Nat. Med., 8, 1098–1104.
Kessler B, Hong X, Petrovic J, Borodovsky A, Dantuma NP, Bogyo M, Overkleeft HS, Ploegh H and Glas R . (2003). J. Biol. Chem., 278, 10013–10021.
Kieff E . (1996). Fields Virology, 3rd edn, Vol. 2, Fiels BN, Knipe DM, Howley PM et al. (eds). Lippincott, Raven Publishers: Philadelphia, pp. 2343–2396.
Kieser A, Kaiser C and Hammerschmidt W . (1999). EMBO J., 18, 2511–2521.
Kim SY, Herbst A, Tworkowski KA, Salghetti SE and Tansey WP . (2003). Mol. Cell, 11, 1177–1188.
Klein G . (1994). Antibiot. Chemoth., 46, 110–116.
Knecht H, Berger C, Rothenberger S, Odermatt BF and Brousset P . (2001). Oncology, 60, 289–302.
Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V and Raab-Traub N . (1998). Proc. Natl. Acad. Sci. USA, 95, 11963–11968.
Lansbury Jr PT and Brice A . (2002). Curr. Opin. Cell Biol., 14, 653–660.
Larsen CN, Krantz BA and Wilkinson KD . (1998). Biochemistry (Moscow), 37, 3358–3368.
Leight ER and Sugden B . (2000). Rev. Med. Virol., 10, 83–100.
Leonchiks A, Stavropoulou V, Sharipo A and Masucci MG . (2002). FEBS Lett., 522, 93–98.
Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG and Masucci MG . (1995). Nature, 375, 685–688.
Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A and Masucci MG . (1997). Proc. Natl. Acad. Sci. USA, 94, 12616–12621.
Liu Y, Fallon L, Lashuel HA, Liu Z and Lansbury Jr PT . (2002). Cell, 111, 209–218.
Longnecker R, Merchant M, Brown ME, Fruehling S, Bickford JO, Ikeda M and Harty RN. . (2000). Exp. Cell Res., 257, 332–340.
Longnecker R, Miller CL, Miao XQ, Tomkinson B and Kieff E . (1993). J. Virol., 67, 2006–2013.
Lorenzo ME, Jung JU and Ploegh HL . (2002). J. Virol., 76, 5522–5531.
Masucci MG and Ernberg I . (1994). Trends Microbiol., 2, 125–130.
Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB and Longnecker R . (1994a). Infect. Agents Dis., 3, 128–136.
Miller CL, Lee JH, Kieff E and Longnecker R . (1994b). Proc. Natl. Acad. Sci. USA, 91, 772–776.
Miyashita EM, Yang B, Babcock GJ and Thorley-Lawson DA . (1997). J. Virol., 71, 4882–4891.
Moorthy R and Thorley-Lawson DA . (1990). J. Virol., 64, 829–837.
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E . (1995). Cell, 80, 389–399.
Mukherjee S, Trivedi P, Dorfman DM, Klein G and Townsend A . (1998). J. Exp. Med., 187, 445–450.
Muller S, Hoege C, Pyrowolakis G and Jentsch S . (2001). Nat. Rev. Mol. Cell Biol., 2, 202–210.
Munger K and Howley PM . (2002). Virus Res., 89, 213–228.
Naze P, Vuillaume I, Destee A, Pasquier F and Sablonniere B . (2002). Neurosci. Lett., 328, 1–4.
Niedobitek G, Baumann I, Brabletz T, Lisner R, Winkelmann C, Helm G and Kirchner T . (2000). J. Pathol., 191, 394–399.
Paludan C and Munz C . (2003). Curr. Mol. Med., 3, 341–347.
Reinstein E, Scheffner M, Oren M, Ciechanover A and Schwartz A . (2000). Oncogene, 19, 5944–5950.
Rickinson AB and Kieff E . (1996). Virology, Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven: Philadelphia, pp. 2397–2446.
Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ and Masucci MG . (1992). Cancer Surv., 13, 53–80.
Rose C, Vargas F, Bourgeat P and Schwartz JC . (1996). Neuropeptides, 30, 231–235.
Rothenberger S, Rousseaux M, Knecht H, Bender FC, Legler DF and Bron C . (2002). Cell. Mol. Life Sci., 59, 171–180.
Rousset R, Desbois C, Bantignies F and Jalinot P . (1996). Nature, 381, 328–331.
Rowe DT, Rowe M, Evan GI, Wallace L, Farrell P and Rickinson AB . (1986). EMBO J., 5, 2599–2607.
Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Trowsdale J, Moss DJ, Rickinson AP and Burrows SR . (1995). Eur. J. Immunol., 25, 1374–1384.
Rowe M, Lear A, Croom-Carter D, Davies A and Rickinson A . (1992). J. Virol., 66, 122–131.
Salghetti SE, Kim SY and Tansey WP . (1999). EMBO J., 18, 717–726.
Sasaki H, Yukiue H, Moriyama S, Kobayashi Y, Nakashima Y, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and Fujii Y . (2001). Jpn. J. Clin. Oncol., 31, 532–535.
Schumacher U, Mitchell BS and Kaiserling E . (1994). DNA Cell Biol., 13, 839–843.
Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, Janek K, Henklein P, Diescher S, Andrieu M, de la Salle H, Weinschenk T, Schild H, Laderach D, Galy A, Haas G, Kloetzel PM, Reiss Y and Hosmalin A . (2003). Nat. Immunol., 4, 375–379.
Sharipo A, Imreh M, Leonchiks A, Brändén CI and Masucci MG . (2001). FEBS Lett., 499, 137–142.
Sharipo A, Imreh M, Leonchiks A, Imreh S and Masucci MG . (1998). Nat. Med., 4, 939–944.
Sohn HW, Gu H and Pierce SK . (2003). J. Exp. Med., 197, 1511–1524.
Spence J, Gali RR, Dittmar G, Sherman F, Karin M and Finley D . (2000). Cell, 102, 67–76.
Staege MS, Lee SP, Frisan T, Mautner J, Scholz S, Pajic A, Rickinson AB, Masucci MG, Polack A and Bornkamm GW . (2002). Proc. Natl. Acad. Sci. USA, 99, 4550–4555.
Takanashi M, Li J, Shirakata M, Mori S and Hirai K . (1999). Arch. Virol., 144, 241–257.
Tezel E, Hibi K, Nagasaka T and Nakao A . (2000). Clin. Cancer Res., 6, 4764–4767.
Thomas J, Allday M and Crawford D . (1991). Adv. Cancer Res., 57, 329–380.
Thorley-Lawson DA . (2001). Nat. Rev. Immunol., 1, 75–82.
Tomkinson B, Hansen M and Cheung WF . (1997). FEBS Lett., 405, 277–280.
von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, Soderberg O, Kerppola TK and Larsson LG . (2003). Mol. Cell, 11, 1189–1200.
Wang EW, Kessler BM, Borodovsky A, Cravatt BF, Bogyo M, Ploegh HL and Glas R . (2000). Proc. Natl. Acad. Sci. USA, 97, 9990–9995.
Wilkinson KD . (2000). Semin. Cell Dev. Biol., 11, 141–148.
Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G, Ingham R, Ernberg I and Pawson T . (2000). Mol. Cell. Biol., 20, 8526–8535.
Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A . (2002). Clin. Cancer Res., 8, 192–195.
Yanagisawa TY, Sasahara Y, Fujie H, Ohashi Y, Minegishi M, Itano M, Morita S, Tsuchiya S, Hayashi Y, Ohi R and Konno T . (1998). Tohoku J. Exp. Med., 184, 229–240.
Yang X, Sham JS, Ng MH, Tsao SW, Zhang D, Lowe SW and Cao L . (2000). J. Virol., 74, 883–891.
Yao T and Cohen RE . (2002). Nature, 419, 403–407.
Zhang Z, Torii N, Furusaka A, Malayaman N, Hu Z and Liang TJ . (2000). J. Biol. Chem., 275, 15157–15165.
Acknowledgements
This research was supported by grants from the Swedish Cancer Society, the Swedish Foundation of Strategy Research, the Petrus och Augusta Hedlunds Stiftelsen, and the Karolinska Institute, Stockholm, Sweden.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masucci, M. Epstein–Barr virus oncogenesis and the ubiquitin–proteasome system. Oncogene 23, 2107–2115 (2004). https://doi.org/10.1038/sj.onc.1207372
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207372
Keywords
This article is cited by
-
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin
Cellular and Molecular Neurobiology (2023)
-
Gene bi-targeting by viral and human miRNAs
BMC Bioinformatics (2010)
-
Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma
Environmental Health (2009)
-
MHC class I antigen presentation: learning from viral evasion strategies
Nature Reviews Immunology (2009)
-
Epstein–Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis
British Journal of Cancer (2008)